Pharma-Vac Form

Your proposed site should be where the majority of your vaccines will be administered and will be the place where vaccine is delivered. There will be flexibility to also vaccinate elsewhere with the consent of the Commissioner. If you think that this is likely, then you can put additional information below. Vaccinations must only be offered where suitable facilities are available and patient dignity and confidentiality can be respected.

Please be realistic when putting forward an Expression of Interest about what is achievable for your proposed site and/or available workforce.
Each ICS and population will have different requirements as to the ideal vaccination capacity and opening hours from a community pharmacy site. In phase 1 and phase 2 we have seen smaller volume pharmacies playing an invaluable role in vaccinating specific populations, and medium and high-volume sites taking pressure off other healthcare providers by operating at scale. Both are valuable and needed in a mixed delivery model. We intend that there will be three types of community pharmacy sites participating in the programme.

1. Low volume sites will be able to administer at least 100 vaccinations per week;
2. Medium volume sites will be able to administer 350 vaccinations or more; and
3. High volume sites will be prepared to administer at least 1000 vaccinations per week.

Note that the LES states that "you may be required to offer vaccinations seven days a week, from 8am to 8pm, including on bank holidays, or during appropriate hours across the week, including weekends, to meet the needs of the local population. Actual delivery hours shall be agreed with the NHSE regional team having regard to the available vaccine supply and the vaccination programme."
If the proposed designated site is on the community pharmacy premises, Pharmacy Contractors may wish to indicate whether they intend to apply to NHS England regional teams to extend their opening hours whilst limiting the provision of other pharmaceutical services from their premises for the purposes of administering COVID-19 vaccines.

This section will ask you to consider what costs, including equipment, you will require support with. There is an expectation that costs and equipment will be required for high and medium volume sites and funding will be made available for that purpose. NHS England is required to assess all potential sites in relation to value for money based on costs against the number of vaccinations likely to be administered from each site. The information that you provide below will allow that assessment to begin, but contractors must not incur any costs without specific written approval from the NHS England regional team to do so. More information is available from the NHS website at Equipment and consumables provision and supply. Please note that these lists continue to be refined and all equipment outlined may not be available for Phase 3.

The Pharmacy Contractor must ensure that the delivery of the vaccination services are accessible, appropriate and sensitive to the needs of all patients. No patient shall be excluded or experience particular difficulty in accessing and effectively accessing vaccination services due to their race, gender, disability, sexual orientation, religion or belief, gender reassignment, marriage or civil partnership status, pregnancy or maternity, or age, employment or carer status. The Pharmacy Contractor must be prepared to provide COVID-19 vaccinations to any patient in an authorised cohort, in priority order unless contraindicated.